Juan José Lahuerta (B Paiva, Bruno Paiva)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 77

Top Venues

Blood

Blood cancer journal

Blood advances

Blood cancer discovery

Fundación de Investigación del Cáncer Universidad de Salamanca

University of Salamanca (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fundación de Investigación del Cáncer Universidad de Salamanca Jan 01 2013 - Jul 31 2013

Spain

Research Fellow

Hospital Universitario de Salamanca Jan 01 2012 - Dec 31 2012

Spain

Postdoctoral Researcher

Hospital Universitario de Salamanca Jul 01 2007 - Jul 01 2011

Spain

Predoctoral Research Fellow

Education History

University of Salamanca - Jun 11 2011

Spain

PHD

Publications

A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Juan José Lahuerta, María-José Calasanz
RASping myeloma genomics. Blood 144 (2) (2024)
Marta Garrote, Marta Español-Rego, Aintzane Zabaleta, Verónica González De La Calle, Sergio Navarro-Velázquez, Susana I Inoges, Ascensión López-Díaz de Cerio, Valentín Cabañas, Nieves López-Muñoz, Paula Rodriguez Otero, Juan Luis Reguera, David F Moreno, Nuria Martinez-Cibrian, Lucía López Corral, Lorena Perez-Amill, Beatriz Martin-Antonio, Laura Rosinol, Joan Cid, Natalia Tovar, Joaquin Saez-Peñataro, Miriam Lopez-Parra, Eulalia Olesti, Elena Guillen, Sara Varea, Luis-Gerardo Rodríguez-Lobato, Anthony Matthew Battram, Marta Sonia González, Andrés Sánchez-Salinas, Europa Azucena González-Navarro, Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prosper, Manel Juan, Joaquin Martinez Lopez, José María M Moraleda, Maria-Victoria Mateos-Manteca, Alvaro Urbano-Ispizua, Juan José Lahuerta, Mariona Pascal, Carlos Fernández de Larrea
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Noemi Puig, Cristina Agullo Roca, Teresa Contreras Sanfeliciano, María-Teresa Cedena, Joaquín Martínez-López, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Belén Iñigo Rodríguez, Anna Sureda, Sunil Lakhwani, Javier de la Rubia Comos, Verónica González De La Calle, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, Sergio Castro, Laura Rosinol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Juan José Lahuerta, Maria-Victoria Mateos-Manteca
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma. Blood (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia. Blood advances (2024)
Marta Garrote, Marta Español-Rego, Aintzane Zabaleta, Verónica González De La Calle, Sergio Navarro-Velázquez, Susana I Inoges, Ascensión López-Díaz de Cerio, Valentín Cabañas, Nieves López-Muñoz, Paula Rodriguez Otero, Juan Luis Reguera, David F Moreno, Nuria Martinez-Cibrian, Lucía López Corral, Lorena Perez-Amill, Beatriz Martin-Antonio, Laura Rosinol, Joan Cid, Natalia Tovar, Joaquin Saez-Peñataro, Miriam Lopez-Parra, Eulalia Olesti, Elena Guillen, Sara Varea, Luis-Gerardo Rodríguez-Lobato, Anthony Matthew Battram, Marta Sonia González, Andrés Sánchez-Salinas, Europa Azucena González-Navarro, Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prosper, Manel Juan, Joaquin Martinez Lopez, José María M Moraleda, Maria-Victoria Mateos-Manteca, Alvaro Urbano-Ispizua, Juan José Lahuerta, Mariona Pascal, Carlos Fernández de Larrea
Biomarkers of efficacy and safety of the academic BCMA-CART ARI0002h for the treatment of refractory multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Nerea Berastegui, Aintzane Zabaleta, Leire Burgos, Diego Alignani, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Susana I Inoges, Ascensión López-Diaz-de-Cerio, Sofia Huerga, Luis Esteban Tamariz-Amador, Jose J Rifon, Ana Alfonso, Juan Jose Lasarte, Juan José Lahuerta, Mikel Hernaez, Paula Rodriguez Otero, Jesús San F Miguel, Teresa Ezponda, Juan Roberto Rodriguez-Madoz, Felipe Prosper
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma. Blood advances (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
Juan José Lahuerta, José-Angel Martinez-Climent
Not so natural, not so killers. Blood 144 (12) (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, María-Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodriguez, Aintzane Zabaleta, Aitziber Lopez, Sarai Sarvide, Laura Blanco, Daniele M Papetti, Marco Salvatore Nobile, Daniela Besozzi, Massimo Gentile, Pierpaolo Correale, Sergio Siragusa, Albert Oriol, Maria Esther González-Garcia, Anna Sureda, Felipe de Arriba, Rafael Rios-Tamayo, José María M Moraleda, Mercedes Gironella, Miguel T Hernandez, Joan Bargay, Luis Palomera, Albert Pérez-Montaña, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo M Roccaro, Alberto Orfao, Joaquin Martinez-Lopez, Laura Rosinol, Juan-José Lahuerta, Joan Bladé, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta, null null, null null
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nature communications 14 (1) (2023)
Catia Simoes, Sara Villar, Beñat Ariceta, Juan-José Garcés, Leire Burgos, Diego Alignani, Sarai Sarvide, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez-Lorenzo, Maria-Belen Vidriales, Carmen Chillon, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa María Ayala, Joaquin Martinez Lopez, Ana Alfonso Pierola, María-José Calasanz, Felipe Prosper, Jesús San F Miguel, Miguel Á Sanz, Juan José Lahuerta, Pau Montesinos, null null
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia. British journal of haematology (2023)
Laura Rosinol, Albert Ortiol, Rafael Rios-Tamayo, María-Jesús Blanchard, Isidro Jarque, Joan Bargay, Miguel-Teodoro T Hernandez Garcia, Valentín Cabañas, Estrella Carrillo-Cruz, Anna Sureda, Joaquin Martinez Lopez, Isabel Krsnik, Maria-Esther Gonzalez, Luis Felipe Casado Montero, Josep-Maria Marti, Cristina Encinas, Felipe de Arriba, Luis Palomera, Maria Antonia Sampol, Yolanda Gonzalez-Montes, Elena Cabezudo, Juan José Lahuerta, Noemi Puig, Maria-Teresa Cedena, Javier de la Cruz, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé
LENALIDOMIDE AND DEXAMETHASONE WITH OR WITHOUT IXAZOMIB MAINTENANCE TAILORED BY RESIDUAL DISEASE STATUS IN MYELOMA. Blood (2023)
Juan José Lahuerta, Irene Manrique, Julie A Rytlewski, Timothy Campbell, Christian C Kazanecki, Nathan Martin, Larry D Anderson, Jesus G Berdeja, Sagar Lonial, Noopur S Raje, Yi Lin, Phillipe Moreau, Jesús San F Miguel, Nikhil C Munshi, Shari Kaiser
Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel. Blood cancer discovery (2023)
Juan José Lahuerta, Anastasiia Zherniakova, Jorge M Nuñez-Córdoba, Paula Rodriguez Otero, Qian Shi, Nikhil C Munshi, Brian Durie, Jesús San F Miguel
Impact of treatment effect on MRD and PFS: an aggregate analysis from randomized clinical trials in multiple myeloma. Blood advances (2023)
Juan José Lahuerta, Jesús San F Miguel
Myeloma evades T cell-engaging therapies. Nature cancer 4 (11) (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, María-José Calasanz, Norma C Gutiérrez, Manuela Fernandez, Albert Ortiol, Rafael Rios-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Laura Rosinol, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Juan José Lahuerta
Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Leire Burgos, Luis Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez Otero, Vladimir Maisnar, Roman Hájek, Frits Van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Juan José Lahuerta, María-José Calasanz
Highs and lows of t(4;14) in multiple myeloma. Blood 141 (13) (2023)
Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Verónica González De La Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, María-Teresa Cedena, Juan José Lahuerta, Laura Rosiñol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood advances 6 (11) (2022)
Alice Nevone, Maria Girelli, Silvia Mangiacavalli, Juan José Lahuerta, Paolo Milani, Pasquale Cascino, Maggie Piscitelli, Valentina Speranzini, Claudio Salvatore Cartia, Pietro Benvenuti, Ibai Goicoechea, Francesca Fazio, Marco Basset, Andrea Foli, Martina Nanci, Giulia Mazzini, Serena Caminito, Melania Antonietta Sesta, Simona Casarini, Paola Rognoni, Francesca Lavatelli, Maria Teresa Petrucci, Pier Paolo Olimpieri, Stefano Ricagno, Luca Arcaini, Giampaolo Merlini, Giovanni Palladini, Mario Nuvolone
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis. Leukemia 36 (8) (2022)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Catia Simoes, Maria Carmen Chillon, David Martínez-Cuadrón, María-José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso, Felipe Prosper, Rosa María Ayala, Joaquin Martínez-López, Juan-Miguel Bergua, Susana Vives, Jose Antonio Perez-Simon, María García-Fortes, Teresa Bernal Del Castillo, Mercedes Colorado, Mayte Olave, Juan I Rodríguez-Gutiérrez, Jorge Labrador, Marcos González-Díaz, Jesús San F Miguel, Miguel A Sanz, Pau Montesinos, Juan José Lahuerta
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia. Blood advances (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martin-Sanchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Juan José Lahuerta, Jesús San F Miguel, Herve Avet-Loiseau
MRD in multiple myeloma: does CR really matter? Blood (2022)
Juan José Lahuerta, Irene Manrique, Meletios A Dimopoulos, Francesca Gay, Chang-Ki Min, Sonja Zweegman, Ivan Spicka, Raphael Teipel, Maria-Victoria Mateos-Manteca, Nicola Giuliani, Michele Cavo, Christine Rojas, Weijun Fu, Kaveri Suryanarayan, Alexander Vorog, Cong Li, Bingxia Wang, Jose Estevam, Richard Labotka, Ajeeta B Dash
MRD dynamics during maintenance for improved prognostication of 1280 myeloma patients in TOURMALINE-MM3 and -MM4 trials. Blood (2022)
Adam David Cohen, Maria-Victoria Mateos-Manteca, Yael C Cohen, Paula Rodriguez Otero, Juan José Lahuerta, Niels W C J van de Donk, Thomas G Martin, Attaya Suvannasankha, Kevin C De Braganca, Christina Corsale, Jordan M Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesús San F Miguel
Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents. Blood (2022)
Sara Rodriguez, Jon Celay, Ibai Goicoechea, Cristina Jiménez, Cirino Botta, Maria-José Garcia-Barchino, Juan-José Garcés, Marta Larrayoz, Susana Santos, Diego Alignani, Amaia Vilas-Zornoza, Cristina Perez, Sonia Garate, Sarai Sarvide, Aitziber Lopez, Hans-Christian Reinhardt, Yolanda R Carrasco, Isidro Sanchez-Garcia, Maria-Jose Larrayoz, María-José Calasanz, Carlos Panizo, Felipe Prosper, José María Lamo-Espinosa, Marina Motta, Alessandra Tucci, Antonio Sacco, Massimo Gentile, Sara Duarte, Helena Vitoria, Catarina Geraldes, Artur Paiva, Noemi Puig, Miriam Santero, Aldo M Roccaro, Gema Fuerte, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta
Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma. Science advances 8 (3) (2022)
Juan-José Garcés, Jesús San F Miguel, Juan José Lahuerta
Reply to I.V. Kostopoulos et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Guillermo Serrano, Marta Garrote, Maria L Palacios-Berraquero, Angel Martin-Mallo, Cristina Calviño-Sampedro, Marta Español-Rego, Candela Ceballos, Teresa Lozano, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Rebeca Martinez-Turrillas, Patricia Jauregui, Diego Alignani, María Cruz Viguria, Margarita Redondo, Mariona Pascal, Beatriz Martin-Antonio, Manel Juan, Alvaro Urbano-Ispizua, Paula Rodriguez Otero, Ana Alfonso, Juan José Lahuerta, Juan Jose Lasarte, Susana Inoges, Ascensión López-Díaz de Cerio, Jesús San F Miguel, Carlos Fernández de Larrea, Mikel Hernaez, Juan Roberto Rodriguez-Madoz, Felipe Prosper
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. Science advances 8 (39) (2022)
Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Ševčíková, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustová, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-José Garcés, Noemi Puig, María-Teresa Cedena, Artur Jurczyszyn, Jorge J Castillo, Miroslav Penka, Jakub Radocha, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, Ludek Pour, Lucie Říhová, Roman Hájek
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Rafael Rios-Tamayo, Juan José Lahuerta, Juan-José Lahuerta, Joaquin Martinez Lopez, Rafael F Duarte
Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal. Cancers 14 (21) (2022)
Juan-José Garcés, Jesús San-Miguel, Juan José Lahuerta
Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora's Box of Multiple Myeloma. Cancers 14 (6) (2022)
Cirino Botta, Catarina Da Silva Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, Maria-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan M Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo M Roccaro, Hartmut Goldschmidt, Herve Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Juan José Lahuerta
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology. Blood advances (2021)
Jesús San F Miguel, Hervé Avet-Loiseau, Juan José Lahuerta, Shaji K Kumar, Meletios A A Dimopoulos, Thierry Facon, Maria-Victoria Mateos-Manteca, Cyrille Touzeau, Andrzej J Jakubowiak, Saad Z Usmani, Gordon Cook, Michele Cavo, Hang Quach, Jon Ukropec, Priya Ramaswami, Huiling Pei, Mia Qi, Steven Sun, Jianping Wang, Maria Krevvata, Nikki DeAngelis, Christoph Heuck, Rian Van Rampelbergh, Anupa Kudva, Rachel Kobos, Ming Qi, Nizar J Bahlis
Sustained Minimal Residual Disease Negativity With Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONE. Blood (2021)
Noemí Puig, Juan A Flores-Montero, Leire Burgos, María-Teresa Cedena, Lourdes Cordón, José-Juan Pérez, Luzalba Sanoja-Flores, Irene Manrique, Paula Rodríguez-Otero, Laura Rosiñol, Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Alberto Orfao, Juan José Lahuerta
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma. Cancers 13 (19) (2021)
Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, Anastasiia Zherniakova, Camilla Guerrero, Aintzane Zabaleta, Leire Burgos, Cirino Botta, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez-Otero, Esperanza Martin-Sanchez, Juan José Lahuerta, null null
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. Blood cancer journal 11 (12) (2021)
Rosa María Ayala, Inmaculada Rapado, Esther Onecha, David Martínez-Cuadrón, Gonzalo Carreno-Tarragona, Juan Miguel Bergua, Susana Vives, Jesus Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla-Rubira, Cristina Gil, Jose Luis López Lorenzo, María Belén Vidriales, Jorge Labrador-Gomez, José Francisco Falantes, María José Sayas, Juan José Lahuerta, Eva Barragán, Felipe Prosper, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos, null On Behalf Of The Programa Para El Estudio de la Terapeutica En Hemopatias Malignas Pethema Cooperative Study Group
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. Cancers 13 (10) (2021)
David L Murray, Noemi Puig, Sigurdur Kristinsson, Saad Z Usmani, Angela Dispenzieri, Giada Bianchi, Shaji K Kumar, Wee Joo Chng, Roman Hájek, Juan José Lahuerta, Anders Waage, Sundararajan Vincent Rajkumar, Brian Durie
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Blood cancer journal 11 (2) (2021)
Daniel Alameda, Ibai Goicoechea, Marco Vicari, Elena Arriazu, Alice Nevone, Sara Rodriguez, Marta Lasa, Noemi Puig, Maria Teresa Cedena, Diego Alignani, Sonia Garate, David Lara-Astiaso, Amaia Vilas-Zornoza, Sarai Sarvide, Enrique María Ocio, Ramon Lecumberri, Alfonso Garcia de Coca, Jorge Labrador, Maria-Esther Gonzalez, Luis Palomera, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Albert Ortiol, Isabel Krsnik, Albert Perez-Montaña, Javier de la Rubia, José Enrique de la Puerta, Felipe de Arriba, Vito Michele Fazio, Joaquin Martinez Lopez, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Maria-Dolores Odero, Felipe Prosper, Assaf Weiner, Ido Amit, Mario Nuvolone, Jesús San F Miguel, Juan José Lahuerta
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood 138 (17) (2021)
Juan José Lahuerta, Maria Vidriales Vicente, Amparo Sempere, Fabián Tarín, Enrique Colado, Celina Benavente, María-Teresa Cedena, Joaquín Sánchez, Teresa Caballero-Velazquez, Lourdes Cordon, Juan-José Garcés, Catia Simoes, David Martínez-Cuadrón, Teresa Bernal Del Castillo, Carmen Botella, Sofia Grille, Josefina Serrano, Carlos Rodríguez-Medina, Lorenzo Algarra, Juan Manuel Alonso-Domínguez, María-Luz Amigo, Manuel Barrios, Raimundo García-Boyero, Mercedes Colorado, Jaime Pérez-Oteyza, Manuel Mateo Pérez Encinas, Lisette Costilla-Barriga, María-José Sayas, Olga Pérez, Marcos González-Díaz, José A Pérez-Simón, Joaquin Martinez Lopez, Claudia Sossa, Alberto Orfao, Jesús F San Miguel, Miguel Angel Sanz, Pau Montesinos, null null
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. Leukemia 35 (8) (2021)
Giovanni Palladini, Juan José Lahuerta, Ashutosh Wechalekar, Margherita Massa, Paolo Milani, Marta Lasa, Sriram Ravichandran, Isabel Krsnik, Marco Basset, Leire Burgos, Mario Nuvolone, Ramón Lecumberri, Andrea Foli, Noemi Puig, Melania Antonietta Sesta, Margherita Bozzola, Pasquale Cascino, Alice Nevone, Jessica Ripepi, Pierpaolo Berti, Simona Casarini, Ombretta Annibali, Alberto Orfao, Jesús San F Miguel, Giampaolo Merlini
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis. Blood cancer journal 11 (2) (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Noemi Puig, Miguel-Teodoro T Hernandez Garcia, Laura Rosiñol, Esther González, Felipe de Arriba, Albert Ortiol, Verónica González-Calle, Fernando Escalante, Javier de la Rubia, Mercedes Gironella, Rafael Ríos, Ricarda García-Sánchez, José M Arguiñano, Adrián Alegre, Jesús Martín-Sánchez, Norma C Gutiérrez, María-José Calasanz, María L Martín, María Del Carmen Couto, María Casanova, Mario Arnao, Ernesto Pérez-Persona, Sebastián Garzón, Marta S González, Guillermo Martín-Sánchez, Enrique M Ocio, Morton Coleman, Cristina Encinas, Ana M Vale, Ana I Teruel, María Cortés-Rodríguez, Juan José Lahuerta, M Teresa Cedena, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé, Ruben Niesvizky, Maria-Victoria Mateos-Manteca
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial. Blood cancer journal 11 (5) (2021)
Arantxa Carrasco-Leon, Teresa Ezponda, Cem Meydan, Luis Vitores Valcárcel, Raquel Ordoñez, Marta Kulis, Leire Garate, Estíbaliz Miranda, Victor Segura, Elisabeth Guruceaga, Amaia Vilas-Zornoza, Diego Alignani, Marién Pascual, Ane Amundarain, Laura Castro-Labrador, Patxi San Martín-Uriz, Halima El-Omri, Ruba Y Taha, María-José Calasanz, Francisco J Planes, Juan José Lahuerta, Christopher E Mason, Jesús San F Miguel, José Ignacio Martin-Subero, Ari M Melnick, Felipe Prosper, Xabier Agirre
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia 35 (5) (2021)
Ana Jiménez-Ubieto, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Ríos, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Sánchez-Pina, Joan Bargay, Maria-Victoria Mateos-Manteca, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan-José Lahuerta, null null
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? Blood 138 (19) (2021)
Michele Cavo, Jesús San F Miguel, Saad Z Usmani, Katja C Weisel, Meletios A A Dimopoulos, Hervé Avet-Loiseau, Juan José Lahuerta, Nizar J Bahlis, Torben Plesner, Vania Tietsche de Moraes Hungria, Philippe Moreau, Maria-Victoria Mateos-Manteca, Aurore Perrot, Shinsuke Iida, Thierry Facon, Shaji K Kumar, Niels W C J van de Donk, Pieter Sonneveld, Andrew Spencer, Maria Krevvata, Christoph Heuck, Jianping Wang, Jon Ukropec, Rachel Kobos, Steven Sun, Mia Qi, Nikhil C Munshi
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, MAIA. Blood (2021)
Rafael Rios-Tamayo, Noemi Puig, Macarena Algarín, José Luís García de Veas Silva, Nuno Barbosa, Cristina Encinas, José Ángel Hernández, Rafael Alonso, María Luisa Campos, Teresa Rodríguez, Joaquin Martinez Lopez, María José Olivares, María José Sánchez, Maria-José Sánchez, Juan José Lahuerta, Joaquín Martínez-López
The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach. Diagnostics (Basel, Switzerland) 11 (11) (2021)
Juan-José Garcés, Gabriel Bretones, Leire Burgos, Rafael Valdes-Mas, Noemi Puig, Maria-Teresa Cedena, Diego Alignani, Idoia Rodriguez, Diana Álvarez Puente, Miguel-García Álvarez, Ibai Goicoechea, Sara Rodriguez, Maria-Jose Calasanz, Xabier Agirre, Juan A Flores-Montero, Luzalba Sanoja-Flores, Paula Rodriguez-Otero, Rafael Rios, Joaquin Martinez-Lopez, Pamela Millacoy, Luis Palomera, Rafael A Del Orbe, Albert Pérez-Montaña, Halima El Omri, Felipe Prosper, Maria-Victoria Mateos-Manteca, Laura Rosiñol, Joan Blade, Juan-Jose Lahuerta, Alberto Orfao, Carlos López-Otín, Jesus F San Miguel, Juan José Lahuerta, null null
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma. Leukemia 34 (11) (2020)
Luciano José Megale Costa, Benjamin A Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C Ye, Curly T C M Morris, Robert F Cornell, Sarah A Holstein, Qian Shi, James Omel, Natalie S Callander, Wee Joo Chng, Vania Hungria, Ângelo Maiolino, Edward Stadtmauer, Sergio A Giralt, Marcelo Pasquini, Andrzej J Jakubowiak, Gareth J Morgan, Amrita Krishnan, Graham H Jackson, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Meletious A Dimopoulos, Thierry Facon, Andrew Spencer, Jesus San Miguel, Parameswaran Hari, Saad Z Usmani, Salomon Manier, Phillip McCarthy, Shaji K Kumar, Francesca Gay, Juan José Lahuerta
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia 35 (1) (2020)
Alejandro Medina Herrera, Noemi Puig, Juan A Flores-Montero, Cristina Jimenez, María Eugenia Sarasquete, María Garcia-Alvarez, Isabel Prieto-Conde, Carmen Chillon, Miguel Alcoceba, Norma C Gutierrez, Albert Oriol, Laura Rosinol, Joan Bladè, Mercedes Gironella, Miguel T Hernandez, Veronica Gonzalez-Calle, Maria-Teresa Cedena, Juan José Lahuerta, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Alberto Orfao, Marcos Gonzalez, Miriam Santero
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma. Blood cancer journal 10 (10) (2020)
Marco Rossi, Emanuela Altomare, Cirino Botta, Maria Eugenia Gallo Cantafio, Sarai Sarvide, Daniele Caracciolo, Caterina Riillo, Marco Gaspari, Domenico Taverna, Francesco Conforti, Paola Critelli, Bernardo Bertucci, Michelangelo Iannone, Nicoletta Polerà, Domenica Scumaci, Mariamena Arbitrio, Nicola Amodio, Maria Teresa Di Martino, Juan José Lahuerta, Pierosandro Tagliaferri, Pierfrancesco Tassone
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma. Leukemia 35 (3) (2020)
Mikèl Sanchez, Diego Delgado, Pello Sánchez, Emma Muiños-López, Juan José Lahuerta, Froilán Granero-Moltó, Felipe Prósper, Orlando Pompei, Juan Carlos Pérez, Juan Azofra, Sabino Padilla, Nicolás Fiz
Combination of Intra-Articular and Intraosseous Injections of Platelet Rich Plasma for Severe Knee Osteoarthritis: A Pilot Study. BioMed research international 2016 (2016)
Emma Muiños-López, Diego Delgado, Pello Sánchez, Juan José Lahuerta, Eduardo Anitua, Nicolás Fiz, Beatriz Aizpurua, Jorge Guadilla, Sabino Padilla, Froilán Granero-Moltó, Felipe Prósper, Mikèl Sanchez
Modulation of Synovial Fluid-Derived Mesenchymal Stem Cells by Intra-Articular and Intraosseous Platelet Rich Plasma Administration. Stem cells international 2016 (2016)

Juan José Lahuerta.css-eqlu8i{font-size:small;padding-left:4px;} (B Paiva, Bruno Paiva)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan José Lahuerta (B Paiva, Bruno Paiva)